Analysts expect Zymeworks Inc. (NYSE:ZYME) to report $-0.54 EPS on March, 13.They anticipate $1.82 EPS change or 142.19% from last quarter’s $1.28 EPS. After having $-0.59 EPS previously, Zymeworks Inc.’s analysts see -8.47% EPS growth. It closed at $15.06 lastly. It is down 61.77% since February 22, 2018 and is uptrending. It has outperformed by 61.77% the S&P500. Some Historical ZYME News: 14/05/2018 – Zymeworks and Daiichi Sankyo Expand Immuno-Oncology Collaboration Focused on Bispecific Antibodies; 14/05/2018 – ZYMEWORKS – DAIICHI SANKYO TO ACQUIRE LICENSES TO CO’S AZYMETRIC AND EFECT TECHNOLOGY PLATFORMS TO DEVELOP 2 ADDITIONAL BISPECIFIC ANTIBODY THERAPEUTICS; 25/04/2018 – Zymeworks Announces Selection of ZW25 Abstract for Oral Presentation at the American Society of Clinical Oncology (ASCO) Annual; 23/04/2018 – ZYMEWORKS & CELGENE EXPAND BISPECIFIC ANTIBODY PACT; 14/05/2018 – ZYMEWORKS- TO GET UPFRONT TECHNOLOGY ACCESS FEE OF $18 MLN; MAY GET UP TO $466.7 MLN IN POTENTIAL CLINICAL, REGULATORY, COMMERCIAL MILESTONE PAYMENTS; 04/05/2018 – Penderfund Capital Buys New 1.3% Position in Zymeworks Inc; 24/04/2018 – Sofinnova leads $32.4 million round for Italy’s EryDel; Celgene expands collaboration with Zymeworks $CELG $ZYME; 23/04/2018 – ZYMEWORKS INC – ZYMEWORKS WILL RECEIVE AN EXPANSION FEE; 14/05/2018 – ZYMEWORKS INC – ZYMEWORKS WILL RECEIVE UP TO DOUBLE-DIGIT TIERED ROYALTIES ON GLOBAL PRODUCT SALES; 23/04/2018 – ZYMEWORKS INC – CELGENE CORP EXERCISED RIGHT TO EXPAND DEAL FOR COMMERCIALIZATION OF BISPECIFIC ANTIBODY THERAPEUTICS USING CO’S AZYMETRIC PLATFORM
Kona Grill Inc (NASDAQ:KONA) had an increase of 2.89% in short interest. KONA’s SI was 961,400 shares in February as released by FINRA. Its up 2.89% from 934,400 shares previously. With 26,500 avg volume, 36 days are for Kona Grill Inc (NASDAQ:KONA)’s short sellers to cover KONA’s short positions. The SI to Kona Grill Inc’s float is 16.46%. The stock increased 2.14% or $0.0199 during the last trading session, reaching $0.9499. About 9,962 shares traded. Kona Grill, Inc. (NASDAQ:KONA) has declined 20.00% since February 22, 2018 and is downtrending. It has underperformed by 20.00% the S&P500. Some Historical KONA News: 19/03/2018 – Kona Gold Solutions, Inc. Announces New Distribution Partner for Its HighDrate CBD Energy Waters; 11/05/2018 – Zheng, Nanyan, Affiliates Report Stake In Kona Grill; 11/05/2018 – NANYAN ZHENG REPORTS 19.9 PCT STAKE IN KONA GRILL INC AS OF MAY 2 – SEC FILING; 21/05/2018 – Hyundai Celebrates Stories of Purposeful Living in ‘The Kona Way’ Content Series; 22/03/2018 – Kona Grill 4Q Loss $12.4M; 22/03/2018 – Kona Gold Solutions, Inc. Enters Distribution and Sales Agreement; 15/03/2018 KONA GRILL INC – 4TH AMENDMENT TO SECOND AMENDED AGREEMENT AMENDS AVAILABLE CREDIT ON REVOLVER WAS REDUCED TO $25 MLN – SEC FILING; 11/05/2018 – NANYAN ZHENG SAYS INTEND TO ENGAGE IN COMMUNICATIONS WITH KONA GRILL AND ONE OR MORE OFFICERS, DIRECTORS OR REPRESENTATIVES OF CO; 22/03/2018 – Kona Grill 4Q Loss/Shr $1.23; 11/05/2018 – NANYAN ZHENG SAYS HAS SUGGESTED ZHENG AS A DIRECTOR OF KONA GRILL’S BOARD
More notable recent Zymeworks Inc. (NYSE:ZYME) news were published by: Seekingalpha.com which released: “Zymeworks outlines 2019 priorities – Seeking Alpha” on January 07, 2019, also Seekingalpha.com with their article: “Zymeworks Inc.: A Blockbuster In The Making – Seeking Alpha” published on December 11, 2018, Seekingalpha.com published: “Zymeworks halted pending news – Seeking Alpha” on June 01, 2018. More interesting news about Zymeworks Inc. (NYSE:ZYME) were released by: Seekingalpha.com and their article: “Zymeworks: Updates To Thesis And 2019 Outlook – Seeking Alpha” published on December 17, 2018 as well as Seekingalpha.com‘s news article titled: “Zymeworks teams up with LEO Pharma in bispecific antibodies – Seeking Alpha” with publication date: October 23, 2018.
Zymeworks Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of bio-therapeutics for the treatment of cancer in Canada. The company has market cap of $481.05 million. The companyÂ’s lead product candidate include ZW25, a novel bispecific antibody that is in Phase I clinical trial for the treatment of breast, gastric, and ovarian cancers. It currently has negative earnings. It is also developing ZW33, a bispecific anti-human epidermal growth factor receptor 2 antibody-drug conjugate that is in preclinical development stage for the treatment of breast and ovarian cancers.
Investors sentiment increased to 1.14 in Q3 2018. Its up 0.01, from 1.13 in 2018Q2. It is positive, as 2 investors sold Kona Grill, Inc. shares while 5 reduced holdings. 3 funds opened positions while 5 raised stakes. 1.69 million shares or 1.40% more from 1.66 million shares in 2018Q2 were reported. California Pub Employees Retirement Sys has invested 0% of its portfolio in Kona Grill, Inc. (NASDAQ:KONA). Dimensional Fund Lp holds 206,739 shares. Renaissance Technology has 850,959 shares. 231,262 were reported by Vanguard. Macquarie Group Incorporated Limited has invested 0% of its portfolio in Kona Grill, Inc. (NASDAQ:KONA). Blackrock accumulated 44,963 shares or 0% of the stock. Northern Trust has invested 0% in Kona Grill, Inc. (NASDAQ:KONA). Citadel Advisors Ltd Com, a Illinois-based fund reported 15,552 shares. Susquehanna Group Llp reported 0% in Kona Grill, Inc. (NASDAQ:KONA). Morgan Stanley, a New York-based fund reported 3,229 shares. Financial Bank Of America De holds 500 shares or 0% of its portfolio. Bnp Paribas Arbitrage Sa owns 2 shares or 0% of their US portfolio. 68 are held by Wells Fargo & Mn. State Street reported 10,880 shares stake. Geode Capital Ltd holds 52,010 shares.
More notable recent Kona Grill, Inc. (NASDAQ:KONA) news were published by: Nasdaq.com which released: “Kona Gold Solutions, Inc. Enters Distribution Agreements with Three Anheuser-Busch Distributors in Missouri – Nasdaq” on February 20, 2019, also Nasdaq.com with their article: “Kona Gold Solutions, Inc. Announces New Distribution Partner in New York – Nasdaq” published on February 12, 2019, Nasdaq.com published: “Kona Gold Solutions, Inc. Acquires Gold Leaf Distribution LLC – Nasdaq” on January 24, 2019. More interesting news about Kona Grill, Inc. (NASDAQ:KONA) were released by: Nasdaq.com and their article: “Kona Gold Solutions, Inc. Announces 2019 Title Sponsorship of Pro Bass Angler Dylan Fulk – Nasdaq” published on January 31, 2019 as well as Nasdaq.com‘s news article titled: “Akamai (AKAM) Earnings and Revenues Beat Estimates in Q4 – Nasdaq” with publication date: February 13, 2019.